Ligand Pharmaceuticals (LGND) Insider: Stock Move Analysis
A Ligand Pharmaceuticals insider recently sold 5,000 shares, triggering discussions about what insider moves signal f...
Find clear guidance on which blue chip coin to start with, including risk notes and a simple starter approach for newcomers.
22,235 articlesA Ligand Pharmaceuticals insider recently sold 5,000 shares, triggering discussions about what insider moves signal f...
As June begins, NVIDIA has surged to the top of investor lists as the biggest June bet on AI infrastructure, backed b...
A broad coalition urges the Senate to take up the CLARITY Act, intensifying the fight over crypto regulation even as ...
When a metropolitan bank director sells shares, it catches the eye of investors. This article explains insider filing...
Bitcoin moved back above the $62,000 mark after a CPI release eased rate-hike fears, signaling a tentative relief ral...
May inflation data show the U.S. economy warming faster than expected, pushing the annual pace of price growth to a t...
AI-driven signals suggest XRP could break out to $1.40-$1.55 in the next 15 days, depending on clearing a key resista...
A modest pullback has the market forecasting a renewed buy-the-dip phase as earnings beat, and credit conditions stab...
Realty Income anchors retiree portfolios with a steady 5.3% yield, supported by robust AFFO coverage and a resilient ...
Anthropic moved to disable access to its Fable 5 and Mythos 5 models after a U.S. export controls directive barred fo...
A federal judge invalidated the White House’s $100,000 H-1B filing fee, creating immediate uncertainty for U.S. emplo...
SpaceX reveals a trillion-dollar revenue forecast, a target far beyond Wall Street estimates and a test of Musk's mos...